Coralynn Sack

Pain affects 100 million adults in the United States (US) and costs up to $635 billion annually. Several interventional treatments have been developed to mitigate the negative impacts of pain. Randomized controlled trials (RCTs) provide the strongest

Background: Within six weeks of the first case of COVID-19 in early Dec 2019 in Wuhan, China, the pandemic had already a foothold half-way around the world in Washington State, where the the first case of COVID-19 in the United States was confirmed on 20 Jan 2020 in a traveler returning from the index city.

Introduction: The expansion of the U.S. cannabis industry has created thousands of new jobs in cultivation, processing and distribution. While little is known about occupational hazards in the Cannabis industry, pilot studies suggest an increased risk of respiratory exposures and associated adverse health outcomes, including immunologic sensitization to Cannabis.

Rationale: Approximately 31% of Chronic Obstructive Pulmonary Disease (COPD) is caused by vapor, gas, dust and fumes (VGDF). In collaboration with the Washington State Department of Labor and Industries Safety and Health Assessment and Research for Prevention Program, we report a new algorithm for surveillance of Occupational COPD.

Introduction: Air pollution is a significant contributor to adverse health outcomes in humans around the world. Particulate matter has been linked to numerous cardiovascular, pulmonary and neurological diseases and associated with increased systemic inflammation and direct cellular toxicity.